Biopharm Research Institute Ltd (BRI) was established in 1983 and has its laboratories and head office in Limassol, Cyprus.

Its activities include the development and synthesis of Active Pharmaceutical Ingredients (APIs), the synthesis of API related substances (Impurities of the Active Substance), the Quality Control of APIs, Impurities and Finished Pharmaceutical Dosage Forms and the preparation of API documentation required by the Pharmaceutical Industry.

It is the policy of the Biopharm Research Institute Ltd to comply with the requirements of Good Laboratory Practice and to continuously improve its performance, quality and service to its customers in all its activities. This commitment underpins our core values of quality, reliability, confidentiality and competitiveness of prices.

Our Research Team consists of highly qualified analytical and synthetic organic chemists. The professionalism and the research experience of the group can assure the best quality of products, accompanied with full spectroscopic characterization data and certificates.

BRI is certified by TÜV Austria for the requirements as per WHO Handbook on Good Laboratory Practice (GLP). This confirms that the company applies GLP guidelines for the following scope:

• Production and Quality Control of raw materials (APIs) for Pharmaceutical Industry.
• Production and Quality Control of Impurities and Working Standards.
• Quality Control of Finished Pharmaceutical Dosage Forms
• Chemical Analysis for the Determination of nitrosamines in API’s and Finished Pharmaceutical Products

BRI is equipped with all the analytical instrumentation necessary for the identification and purity determination of compounds.

Our company offers you the opportunity to send a request for any of our available/new product you require. After your request has been sent, you will receive an official quotation by one of our R&D specialists. You can always select from our available products* which can be despatched immediately.

^{*Eur. Ph. names (e.g. Ambroxol Impurity A) are used for impurities of any API with a Eur. Ph. monograph. Other API related substances with no monograph, are found under their IUPAC name.}